Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Share News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen launches 'Rinodrive' artificial intelligence platform

Tue, 29th Oct 2019 12:16

(Sharecast News) - Integumen announced the launch of 'Rinodrive' as an independent artificial intelligence (AI) platform for collaboration and joint venture partners on Tuesday, as an open-source cloud-based ecosystem.
The AIM-traded firm said the stand-alone platform was currently being rolled out with existing healthcare clients, a growing list of higher educational establishments, and was being tested in government departments, in a "reputable UK bank" and an international financial advisory firm.

Since 2016, Rinocloud - a wholly-owned subsidiary of Integumen - had developed Rinodrive as a data aggregation, refining and AI analysis open-source ecosystem, designed to provide third-party service providers with the ability to offer their clients insights that supported clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

"Following the transformational change with the Integumen business model achieved in just a few months by adding AI to Labskin, we are now delighted to be able to offer the same benefits across multiple industries," said chief executive officer Gerard Brandon.

"Rinodrive will act as an independent AI platform which will allow the management of Integumen to remain focused on their core Labskin AI business while deriving revenues from clients across healthcare services, third-level education, government departments and the financial sector.

"In the three years prior to the Rinocloud acquisition in May 2019, Rinodrive had been developed to deal with the explosive growth of data across multiple industries."

Brandon said the company had seen it successfully work with genetic data at Labskin, and also at various scientific data at research institutes such as the University College Cork, Cambridge University and the Centre for Advanced Photonics and Process Analysis at the Cork Institute of Technology.

"Rinodrive AI is now ready to help our clients and partners advance their work beyond Labskin and add a further revenue sharing source of income as we head into 2020."
More News
30 Sep 2020 17:10

Integumen enters deal with Detroit water quality non-profit

(Sharecast News) - Integumen has signed a memorandum of understanding with Detroit-based non-profit organisation Water Rising Institute, it announced on Wednesday, to enter a legally-binding three-year framework agreement.

Read more
25 Sep 2020 10:32

UK WINNERS & LOSERS SUMMARY: Boohoo Rallies After Supply Chain Review

UK WINNERS & LOSERS SUMMARY: Boohoo Rallies After Supply Chain Review

Read more
25 Sep 2020 10:21

Integumen And Modern Water Get Publication Date Extension For Merger

Integumen And Modern Water Get Publication Date Extension For Merger

Read more
18 Sep 2020 14:23

IN BRIEF: Integumen Revenue Jumps But Loss Only Slightly Narrows

IN BRIEF: Integumen Revenue Jumps But Loss Only Slightly Narrows

Read more
28 Aug 2020 13:20

Integumen agrees deal to take over Modern Water

(Sharecast News) - Integumen and Modern Water have reached agreement on the terms of a recommended offer to be made by Integumen for the entire issued and to be issued share capital of Modern Water, they announced on Friday.

Read more
28 Aug 2020 10:47

Integumen Agrees GBP21 Million All-Share Acquisition Of Modern Water

Integumen Agrees GBP21 Million All-Share Acquisition Of Modern Water

Read more
29 Jul 2020 21:19

IN BRIEF: Integumen Secures GBP3 Million Facility For Working Capital

IN BRIEF: Integumen Secures GBP3 Million Facility For Working Capital

Read more
29 Jul 2020 13:53

Integumen secures £3m loan to fund Covid-19 AI goals

(Sharecast News) - Integumen announced on Wednesday that it has secured a £3m, three-year loan facility with Riverfort Global Opportunities and YA II PN.

Read more
24 Jul 2020 15:37

Integumen's Labskin launches remote clinical trials platform

(Sharecast News) - Integumen announced on Friday that its subsidiary Labskin was launching its remote clinical skin trials platform, which it claimed was the world's first of its type.

Read more
24 Jul 2020 13:56

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

Read more
13 Jul 2020 11:23

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Read more
13 Jul 2020 09:18

Avacta signs Covid sewage test deal with Integumen

(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.

Read more
23 Jun 2020 06:47

IN BRIEF: Integumen Signs Covid Identification Pact With Aptamer Group

IN BRIEF: Integumen Signs Covid Identification Pact With Aptamer Group

Read more
22 Jun 2020 16:36

Integumen signs deal for Covid-19 detection in wastewater

(Sharecast News) - Integumen has signed a material transfer agreement with the Aptamer Group, it announced on Monday, to develop and manufacture aptamers to detect SARS-CoV-2, or Covid-19, in wastewater.

Read more
15 Jun 2020 13:54

UPDATE: Integumen Obtains GBP400,000 Loan From Cellulac

UPDATE: Integumen Obtains GBP400,000 Loan From Cellulac

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.